Lowstar Tablet 80/5 mg

Adult dose

The recommended dosage of this medication is one tablet once daily, to be taken with water regardless of meals. It is recommended to take it at the same time every day (e.g., in the morning). 40/5 mg: Administered to patients whose blood pressure is not adequately controlled with Amlodipine 5 mg or Telmisartan 40 mg. 80/5 mg: Administered to patients whose blood pressure is not adequately controlled with Amlodipine 5 mg or this medication 40/5 mg.

Child dose

Safety and efficacy for pediatric patients under 18 years have not been established, hence the administration of this drug is not recommended.

This drug should not be used during pregnancy, especially in the second and third trimesters, as it can cause serious health problems for the fetus or newborn. This drug should not be administered to women with certain allergic reactions, pregnant women, nursing mothers, patients with severe liver dysfunction, or patients with very low blood pressure. Patients with primary aldosteronism, cardiac valve disease, impaired liver function, gastrointestinal disorders, and renal dysfunction need to exercise special caution when using this drug. Common side effects such as dizziness or peripheral edema may appear when taking this medication, and rare but serious side effects may also occur, so any abnormal symptoms should prompt immediate consultation with a doctor. Women who are pregnant or planning to become pregnant should be switched to other antihypertensive drugs with confirmed safety instead of this medication, and the use of this drug should be immediately discontinued upon confirmation of pregnancy. Patients who are dehydrated or have low salt levels should be especially careful as they may experience symptoms of hypotension, and where necessary, appropriate steps should be taken under a doctor's direction. This medication can increase serum potassium levels, hence when taken with potassium-containing supplements or other drugs, serum potassium levels should be monitored regularly through blood tests. Patients with impaired kidney function should have their kidney function and serum electrolyte levels regularly monitored while taking this drug. Patients with heart disease or heart failure should be carefully monitored as symptoms may worsen after taking this medication, and dosage adjustments may be necessary. This drug may interact with other medications that inhibit or induce certain enzymes, so it is essential to inform healthcare providers about any other medications being taken. Caution is advised when driving or operating hazardous machinery, as dizziness or drowsiness may occur during the use of this medication. In cases of overdose, symptoms such as low blood pressure, dizziness, and heart rhythm abnormalities may appear, requiring immediate medical treatment. This medication is not recommended for children or adolescents under 18 years of age due to insufficient evidence of safety and efficacy. For the elderly, dosage should be adjusted and increased gradually based on careful observation of the response to the medication. This drug should be kept out of reach of children, and it is best to store it in its original packaging.

Serious side effects

• Urticaria, severe swelling (angioedema), chest tightness, difficulty breathing, cold sweat, pallor, severe allergic reaction
• Severe rash with high fever, blisters, skin peeling, pain in the mucous membranes of the mouth/eyes, severe adverse skin reactions
• Respiratory distress, asthma attacks, cough with fever accompanying respiratory abnormalities
• Liver abnormalities (including jaundice): yellowing of the skin or eyes (jaundice), liver function abnormalities, hepatitis, increased liver enzymes
• Severe neurological symptoms

Mild side effects

• Dizziness
• peripheral edema
• fainting
• drowsiness
• headache
• paresthesia
• taste disturbances
• tremor
• visual disturbances
• vertigo

This drug is sensitive to light, so it should be stored in a container that does not allow light in. Additionally, it is important to store the medication at room temperature between 1 and 30 degrees Celsius to maintain its efficacy.

Appearance

A white and light gray, double-layered, oval biconvex tablet.

Package unit

30 tablets / PTP [10 tablets / PTPX3]